Posted on August 1st, 2010 by
A new study from the University of New Mexico Cancer Canter says some elderly leukemia patients aren’t getting the best treatments available. The study’s author, Doctor Robert Hromas, tells 770 KKOB that us older chronic myeloid leukemia patients are not getting the drug “Gleevec” to the same degree as younger patients. Link
Tags: In the News
You must be logged-in to the site to post a comment.